Four batches of EpiPens are being recalled thanks to a possible defect that may prevent them from injecting properly.
It affects the 300 microgram adrenaline injection syringe auto-injectors with a batch number of 5FA665, 5FA6651, 5FA6652, 5FA6653 and an expiry date of April 2017.
EpiPens are used in emergency situations to treat people who are having severe allergic reaction and if they don't activate properly, there is a risk a patient may not receive the adrenaline they need.
The Government's Therapeutic Goods Administration has confirmed two reports of auto-injectors from these batches failing to activate correctly, out of about 80,000 devices distributed worldwide.
No other batches of EpiPen, including the EpiPen Jr 150 microgram version, are thought to be affected.